Search

everythinglearnresearchcommunity

for

Search:↓

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

A dermoscope helps accurately tell apart Pityrosporum folliculitis and Acne vulgaris.

People with alopecia have a higher risk of thyroid cancer.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

Certain skin drugs and topical agents, including some natural extracts and fragrances, can cause allergic reactions. Some hair dyes and extensions, as well as minoxidil, a hair growth treatment, can also cause allergies. Botulinum toxin A can effectively reduce sweat but may have temporary side effects.

Hydrogel scaffolds can help wounds heal better and grow hair.

Recognizing specific skin features helps diagnose and manage lupus erythematosus effectively.

Oral cyclosporin doesn't stop hair loss.

Hairless protein is key for hair growth, cell differences cause gene expression variation, and the N-end rule pathway senses nitric oxide for protein breakdown.

COVID-19 vaccines have been linked to an increase in hair loss conditions.

Protein analysis shows aging changes in scalp cell types from women.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Certain drugs like Dutasteride and Finasteride might help fight SARS-CoV-2 by increasing levels of a steroid called DHEA, which can protect the heart and increase nitric oxide to counteract the virus.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Low testosterone levels may lead to more severe COVID-19 outcomes.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Anabolic steroid users may face higher risk of severe COVID-19.

Hair loss doesn't affect COVID-19 severity.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.